Antidepressants Don't Prevent Smoking Among ADHD Patients, Study SaysSeptember 12, 2007
Research Summary
The antidepressant bupropion is ineffective in preventing smoking among youths with attention-deficit/hyperactivity disorder (ADHD), Reuters reported Aug. 29.
Bupropion is sold as Zyban as a stop-smoking aid and as Wellbutrin for treating depression or seasonal-affective disorder. Since youth with ADHD are at high risk for smoking, it was hoped that the drug would have a preventive effect in this population.
But researchers found that a placebo group had a far lower rate of nicotine exposure than a group receiving bupropion. On the other hand, stimulants did appear to cut smoking risk.
The study was published in the July 2007 issue of the Journal of Clinical Psychiatry.
This article
summarizes an external report or press release on research published in a scientific journal. When available, links to the sources are provided above.
COMMENTS ON THIS ARTICLE: